Abstract:Exposure to ionizing radiation alone or combined with traumatic tissue injury is a crucial life-threatening factor in nuclear and radiological incidents. Radiation injuries occur at the molecular, cellular, tissue and systemic levels; their mechanisms, however, remain largely unclear. Exposure to radiation combined with skin wounding, bacterial infection or burns results in greater mortality than radiation exposure alone in dogs, pigs, rats, guinea pigs and mice. In the current study we observed that B6D2F1/J female mice exposed to 60Co gamma-photon radiation followed by 15% total-body-surface-area skin wounds experienced an increment of 25% higher mortality over a 30-day observation period compared to those subjected to radiation alone. Radiation exposure delayed wound healing by approximately 14 days. On day 30 post-injury, bone marrow and ileum in animals from both groups (radiation alone or combined injury) still displayed low cellularity and structural damage. White blood cell counts, e.g., neutrophils, lymphocytes, monocytes, eosinophils, basophils and platelets, still remained very low in surviving irradiated alone animals, whereas only the lymphocyte count was low in surviving combined injury animals. Likewise, in surviving animals from radiation alone and combined injury groups, the RBCs, hemoglobin, hematocrit and platelets remained low. We observed, that animals treated with both pegylated G-CSF (a cytokine for neutrophil maturation and mobilization) and Alxn4100TPO (a thrombopoietin receptor agonist) at 4 h postirradiation, a 95% survival (vehicle: 60%) over the 30-day period, along with mitigated body-weight loss and significantly reduced acute radiation syndrome. In animals that received combined treatment of radiation and injury that received pegylated G-CSF and Alxn4100TPO, survival was increased from 35% to 55%, but did not accelerate wound healing. Hematopoiesis and ileum showed significant improvement in animals from both groups (irradiation alone and combined injury) when treated with pegylated G-CSF and Alxn4100TPO. Treatment with pegylated G-CSF alone increased survival after irradiation alone and combined injury by 33% and 15%, respectively, and further delayed wound healing, but increased WBC, RBC and platelet counts after irradiation alone, and only RBCs and platelets after combined injury. Treatment with Alxn4100TPO alone increased survival after both irradiation alone and combined injury by 4 and 23%, respectively, and delayed wound healing after combined injury, but increased RBCs, hemoglobin concentrations, hematocrit values and platelets after irradiation alone and only platelets after combined injury. Taken together, the results suggest that combined treatment with pegylated G-CSF and Alxn4100TPO is effective for mitigating effects of both radiation alone and in combination with injury.

Therapeutic effect of GW003 on rhesus monkeys with acute radiation injuries

Therapeutic Effect of Recombinant Human Serum Albumin-Granulocyte Colony-Stimulating Factor Fusion Protein on Mice with Acute Radiation Sickness

Mobilization Effects of Recombinant Human Serum Albumin-Granulocyte Colony-Stimulating Factor Fusion Protein on Peripheral Hematopoietic Cells of Rhesus Monkeys

[Therapeutic Effect of Recombinant Human Stem Cell Factor on Rhesus Monkeys with Severe Acute Radiation Sickness].

[Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].

Radioprotective Effects of CBLB502 on Γ-Radiated Rhesus Monkey

Therapeutic Effect of Recombinant Human Serum Albumin-Granulocyte Colony-Stimulating Factor Fusion Protein on Rats Undergoing Chemotherapy

Effects of High Dose Ionizing Radiation on Histopathological Changes and Expression of Related Cytokines in Rhesus Monkeys (Macaca mulatta)

Administration of Recombinant Human Thrombopoietin Soon after Irradiation Promotes Survival and Stimulates Hematopoietic Recovery in a Nonhuman Primate Model of Radiation-Induced Severe Acute Radiation Syndrome

Preclinical Safety Evaluation of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Rhesus Monkey

[Therapeutic Effect of the Recombinant Human Granulocyto Colony-Stiimulating Factor on Radiation-Induced Agranulocytosis Models of Mice].

Effect of Rhg-Csf on Blood Coagulation in Beagles Irradiated by 2.3 Gy Neutron

Therapeutic Effects of Combined Cytokines on Hematopoietic Injuries Induced by 4.5 Gy Γ-Rays Irradiation in Beagles

Studies on Mechanism of Treatment of Granulocyte Colony-Stimulating Factor,recombinant Human Interleukin-11 and Recombinant Human Interleukin-2 on Hematopoietic Injuries Induced by 4.5 Gy Γ-Rays Irradiation in Beagles

Sequential administration of delta-tocotrienol ameliorates radiation-induced myelosuppression in mice and non-human primates through inducing G-CSF production

High Dose Granulocyte Colony-Stimulating Factor Enhances Survival and Hematopoietic Reconstruction in Canines Irradiated by 2.3 Gy Mixed Fission Neutron and Gamma Ray.

Study on the Therapeutic Effect of Cytokine on Acute Radiation Syndrome Induced by 60Co γ Ray Exposure

BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome

RhG-CSF Improves Radiation-induced Myelosuppression and Survival in the Canine Exposed to Fission Neutron Irradiation

Co-Therapy of Pegylated G-CSF and Ghrelin for Enhancing Survival After Exposure to Lethal Radiation

Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation Alone and Followed by Wound Trauma